Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Risperidone - Janssen

Next Previous
Drug Profile

Risperidone - Janssen

Alternative Names: JNJ 410397 AAA; R 64766; R064766; Risperdal; Risperdal Consta; Risperdal Depot

Latest Information Update: 08 Jan 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Janssen L.P.
  • Developer Alkermes; Janssen; Janssen L.P.; Janssen Pharmaceutical KK; Janssen-Cilag; Xian-Janssen
  • Class Antidepressants; Antineoplastics; Antipsychotics; Behavioural disorder therapies; Fluorinated hydrocarbons; Isoxazoles; Mood stabilisers; Piperidines; Pyrimidinones; Small molecules
  • Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 5-HT2A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Aggression; Autistic disorder; Bipolar disorders; Dementia; Schizophrenia
  • No development reported Anxiety disorders; Major depressive disorder; Obsessive-compulsive disorders
  • Discontinued Gilles de la Tourette's syndrome; Substance-related disorders

Most Recent Events

  • 25 Oct 2025 Launched for Schizophrenia (In adolescents) in Spain (PO)
  • 04 Dec 2023 m8 Pharmaceuticals has been acquired by Acino
  • 12 Apr 2021 Discontinued - Phase-II for Substance-related disorders in USA (IM)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top